Stay updated on Precision 1 Clinical Trial: Nab-sirolimus in TSC1/TSC2 Gene Tumors
Sign up to get notified when there's something new on the Precision 1 Clinical Trial: Nab-sirolimus in TSC1/TSC2 Gene Tumors page.

Latest updates to the Precision 1 Clinical Trial: Nab-sirolimus in TSC1/TSC2 Gene Tumors page
- ChecktodayNo Change Detected
- Check7 days agoNo Change Detected
- Check15 days agoChange Detected- Updated operating-status notice and new version tag (v3.2.0) added; old version tag (v3.1.0) removed. The page now provides current status guidance and a newer software/document version.SummaryDifference2%
- Check22 days agoChange DetectedUpdated the page revision from v3.0.2 to v3.1.0, indicating a new version but no substantive content changes.SummaryDifference0.0%
- Check36 days agoChange DetectedUpdated the page revision to v3.0.2 and removed the Back to Top element. No substantive changes to core content, pricing, stock, or other critical information.SummaryDifference0.1%
- Check44 days agoChange DetectedThe web page has been updated from version 3.0.0 to 3.0.1, indicating a revision in the content. There are no significant changes in core content, pricing, or availability.SummaryDifference0.1%
- Check51 days agoChange DetectedThe web page has been updated to include new facility names and locations, as well as additional medical topics related to cancer and genetic diseases. Notably, the previous version's specific drug information and certain location details have been removed.SummaryDifference7%
- Check65 days agoChange DetectedThe web page has been updated from version 2.16.11 to version 2.16.12.SummaryDifference0.0%
Stay in the know with updates to Precision 1 Clinical Trial: Nab-sirolimus in TSC1/TSC2 Gene Tumors
Enter your email address, and we'll notify you when there's something new on the Precision 1 Clinical Trial: Nab-sirolimus in TSC1/TSC2 Gene Tumors page.